Moderna Disputes Claims By NIH đź’‰

by 12 Nov, 2021

Moderna Disputes Claims By NIH

The tide is turning against Moderna, the once red-hot Covid-19 vaccine developer.

Moderna is disputing some claims by the National Institutes of Health that it was behind the invention of the company’s mRNA coronavirus vaccine.

Moderna said in a statement Tuesday: “Moderna has all along recognized the substantial role that NIH has played in developing Moderna’s coronavirus vaccine.”

That includes acknowledging that scientists from NIH made inventive contributions during the developing the vaccine including them as co-inventors on patent applications that have also been published recently with claims to the use of mRNA-1273.

Moderna just recently defended the use of its Covid-19 vaccine on Thursday, saying the protection it offers against severe disease, hospitalization, and death outweighs the risk of myocarditis, a rare heart condition seen in a small number of young men who received the shot.

“Reported cases of rare heart inflammation in men under 30 are relatively higher after Moderna’s vaccine compared with Pfizer’s”, said Chief Medical Officer Dr. Paul Burton.

However, he also touted data from the CDC that showed the rates of mild or severe disease from Covid were lower in Moderna recipients.

“There were only 86 breakthrough cases per 100,000 people for the Moderna vaccine. That compares to 135 breakthrough cases per 100,000 for Pfizer’s”, he said.

“While I think health authorities are carefully assessing the data, being appropriately cautious, you can see that they continue to recommend the use of the mRNA-1273 Moderna vaccine.”

More than 71 million Americans are fully vaccinated with the Moderna vaccine, according to data compiled by the CDC.

I am not a financial advisor and my comments should never be taken as financial advice. Investments come with risk, so always do your research and analysis beforehand.

All emails include an unsubscribe link. You can opt-out at any time. ​See our privacy policy.

All emails include an unsubscribe link. You can opt-out at any time. ​See our privacy policy.

Invstr
(2K)
Get the app
Share This